Biotechnology has significantly advanced vaccine development, enabling the creation of more effective and targeted immunizations. This book examines the role of biotechnological techniques in the design, production, and optimization of vaccines, including recombinant DNA technology, mRNA platforms, and viral vector systems. It explores the processes of antigen selection, adjuvant formulation, and vaccine delivery systems, as well as the regulatory and manufacturing considerations unique to biotechnological vaccines. Designed for immunologists, biotechnologists, and pharmaceutical scientists, the book provides a comprehensive overview of how biotechnology is shaping the future of vaccine development and public health.
Sebastian Harrison is an expert dermatologist specializing in the role of biotechnology in vaccine development, focusing on the creation and optimization of vaccines for dermatological conditions and skin-related diseases. His research investigates the use of recombinant DNA technology, viral vectors, and mRNA platforms to develop effective and safe vaccines targeting viral skin infections, melanoma, and other skin-related malignancies. Sebastian has authored numerous studies on the advancements and applications of biotechnological methods in enhancing vaccine efficacy, stability, and delivery for dermatological use. He has developed comprehensive biotechnological vaccine development protocols that enhance the prevention and treatment options for skin health.